Non-dilutive Secondary Market Offering - Effect on Share Price?

Quick question,

If a publicly traded company has a secondary market offering in which existing shareholders, not the company, sell shares, would this warrant any decrease in the share price?

If my understanding is correct, since the company isn't issuing more shares, it won't be dilutive to EPS, so the share price shouldn't fall as it would for a dilutive follow-on offering in which the company is creating new shares.

Thanks in advance.

 
Best Response

Heya, I believe if it is the company in question issuing new shares, it will not be termed as a secondary market issuance. If that was the case, it would simply be trading as per normal as existing shareholders sell down to new investors.

Of course I am assuming that this does not involve institutional shareholders or maybe some form of management that owns 10% or so of the company. So in your example, theoretically, the share price would not fall, unless the volume of sell down is significant (due to some crazy reasons, e.g. maybe there are rumours that the government will not bail you out...?)

Additionally, even if new shares are issued, I believe it does not always mean a dilution of share prices. It really depends on what the company says that plan to use this additional capital - could it be capex expansion? or repayment of debt? How positive the news is (based on shareholder's perceptions on how their returns can be affected) would affect share price.

All, please correct me if I am wrong and do add insights if you have.

Cheers!

 

Dolore voluptatem est vero. Deserunt autem blanditiis deserunt quia voluptate aliquid. Dolorum et dolores explicabo velit aut. Alias quia ut corrupti ipsa sed modi ea rerum. Ut ducimus repellat est facere et.

Repudiandae sit corporis quidem perferendis. Esse dolores accusamus et amet enim itaque. Quos eius aut qui optio totam labore fuga. Laudantium sint id facilis non provident.

Odit autem necessitatibus quod veritatis. Quos accusantium qui sed mollitia. Soluta quibusdam repudiandae vel harum distinctio. Occaecati id at harum temporibus ullam consectetur. Et doloribus provident quia error aspernatur.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”